Sol-Gel Technologies/SLGL

$0.78

-3.1%
-
1D1W1MYTD1YMAX

About Sol-Gel Technologies

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

Ticker

SLGL

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Alon Seri-Levy

Employees

36

Headquarters

Ness-ziona, Israel

SLGL Metrics

BasicAdvanced
$22M
Market cap
-
P/E ratio
-$0.82
EPS
1.54
Beta
-
Dividend rate
$22M
1.54065
$4.05
$0.63
34K
6.891
-51.4%
-59.6%
-57.29%
13.038
0.687
0.687
-58.84%
1.3%
-43.83%

What the Analysts think about SLGL

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 2 analysts.
669.23% upside
High $6.00
Low $6.00
$0.78
Current price
$6.00
Average price target

SLGL Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,575% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$400K
0%
Net income
-$6.3M
31.25%
Profit margin
-1,575%
31.25%

SLGL Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 53.33%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.22
-$0.21
-$0.17
-$0.23
-
Expected
-$0.26
-$0.23
-$0.18
-$0.15
-$0.20
Surprise
-13.73%
-8.7%
-2.86%
53.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Sol-Gel Technologies stock?

Sol-Gel Technologies (SLGL) has a market cap of $22M as of May 30, 2024.

What is the P/E ratio for Sol-Gel Technologies stock?

The price to earnings (P/E) ratio for Sol-Gel Technologies (SLGL) stock is 0 as of May 30, 2024.

Does Sol-Gel Technologies stock pay dividends?

No, Sol-Gel Technologies (SLGL) stock does not pay dividends to its shareholders as of May 30, 2024.

When is the next Sol-Gel Technologies dividend payment date?

Sol-Gel Technologies (SLGL) stock does not pay dividends to its shareholders.

What is the beta indicator for Sol-Gel Technologies?

Sol-Gel Technologies (SLGL) has a beta rating of 1.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Sol-Gel Technologies stock price target?

The target price for Sol-Gel Technologies (SLGL) stock is $6, which is 669.23% above the current price of $0.78. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Sol-Gel Technologies stock

Buy or sell Sol-Gel Technologies stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing